Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn's Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab

Schreidah, C. M., Fahmy, L. M., Lapolla, B. A., Kwinta, B. D., Magro, C. M., & Geskin, L. J. (2023). Clinical Remission of Primary Cutaneous Marginal Zone B-Cell Lymphoma in a Patient With Crohn’s Disease After Helicobacter pylori Quadruple Therapy and Vedolizumab. The American Journal of Dermatopathology, 45(8), 572–576. https://doi.org/10.1097/dad.0000000000002470
Authors:
Celine M Schreidah
Lauren M Fahmy
Brigit A Lapolla
Bradley D Kwinta
Cynthia M Magro
Larisa J Geskin
Affiliated Authors:
Celine M Schreidah
Lauren M Fahmy
Brigit A Lapolla
Bradley D Kwinta
Larisa J Geskin
Columbia Affiliation:
Subjects:
Crohn Disease (MeSH)
Lymphoma, B-Cell, Marginal Zone (MeSH)
Helicobacter pylori (MeSH)
Stomach Neoplasms (MeSH)
Author Keywords:
b-cell lymphoma
crohn's disease
heliobacter pylori
inflammatory bowel disease
marginal zone lymphoma
mucosa-associated lymphoid tissue
primary cutaneous marginal zone b-cell lymphoma
quadruple therapy
vedolizumab
elink
Publication Type:
Article
Unique ID:
10.1097/dad.0000000000002470
PMID:
37377200
DOI:
10.1097/dad.0000000000002470
Journal:
American Journal of Dermatopathology
Publication Date:
Data Source:
PubMed
Source Link:
View PubMed Record
View Scopus Record

Record Created: